Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gandhi, P.
Right arrow Articles by Ramaswamy, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gandhi, P.
Right arrow Articles by Ramaswamy, K
American Journal of Health-System Pharmacy, Vol 60, Issue 23, 2479-2483
Copyright © 2003 by American Society of Health-System Pharmacists

Articles

Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient

PJ Gandhi, PA Menezes, HT Vu, AL Rivera, and K Ramaswamy


Patients initiated on fluconazole and levofloxacin should be closely monitored for QTc-interval prolongation. While there have been published reports of fluconazole and levofloxacin causing QTc-interval prolongation when given alone, coadministration of these two agents may further increase this risk. This case describes an episode of TdP in which levofloxacin and fluconazole were likely significant factors. QT prolongation was present at baseline prior to drug initiation (QTc = 454-505 ms) and levofloxacin resulted in further prolongation (QTc = 480-536 ms). After two days of therapy with fluconazole, overlapping with levofloxacin, the patient had an episode of PMVT with syncope, and progressive QT prolongation was evident (QTc = 554 ms). Only mild hypokalemia (potassium concentration = 3.6 meq/L) was present, and not additional etiologies for TdP were identified. Levofloxacin and fluconazole were discontinued and no further PMVT was observed, but the QT interval did not return to normal until after an additional 11 days (QTc = 436 ms). As in many cases of TdP, multiple factors were involved. Renal failure, drug dosing, mild hypokalemia, and a baseline abnormal QT interval potentiated the role of levofloxacin and fluconazole in the development of TdP. We recommend that neither drug be used alone or in combination when there is baseline QT prolongation. We also recommend that concomitant use of these agents be avoided when possible. If combination therapy is required, caution is warranted, particularly in patients with risk factors for QT prolongation. Specific attention should be given to drug dosing, interactions, electrolytes, and ECG monitoring.
 



This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
J. H. McMahon and M. L. Grayson
Torsades de pointes in a patient receiving fluconazole for cerebral cryptococcosis
Am. J. Health Syst. Pharm., April 1, 2008; 65(7): 619 - 623.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
T. M. Ng, A. M Bell, C. Hong, J. M Hara, D. R Touchette, K. N Danskey, T. T Lindsay, and S. E Puumala
Pharmacist Monitoring of QTc Interval-Prolonging Medications in Critically Ill Medical Patients: A Pilot Study
Ann. Pharmacother., April 1, 2008; 42(4): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
C P. Pham, P. W de Feiter, P H. M van der Kuy, and W. N. van Mook
Long QTc Interval and Torsade de Pointes Caused by Fluconazole
Ann. Pharmacother., July 1, 2006; 40(7): 1456 - 1461.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society of Health-System Pharmacists.